Tag Archives: cognition

Breaking Down The Brain: The Most Complex Neural Map Ever, Now Complete

Investigators at the forefront of neuroscience have just unveiled the most comprehensive neural map ever created – a milestone achievement comparable in scope and impact to the Human Genome Project.

As part of the MICrONS (Machine Intelligence from Cortical Networks) project – funded by the U.S. Defense Advanced Research Projects Agency (DARPA) under the BRAIN Initiative – scientists have completed the most detailed reconstruction to date of a mammalian brain region. The collaborative effort brought together over 150 researchers across multiple institutions to focus on a one-cubic-millimeter section of mouse visual cortex.

Despite its size being smaller than a grain of rice, the mapped volume contains approximately 200,000 cells, four kilometers of axons, and more than 523 million synapses. It is the most comprehensive cellular and synaptic wiring diagram ever produced for a piece of mammalian brain tissue and the first to integrate both structural and functional data at this scale.

Continue reading

The Drugs That Keep On Giving? 
Study Finds Unexpected Neuroprotective Benefits Of GLP-Agonists 

The Drugs That Keep On Giving? Study Finds Unexpected Neuroprotective Benefits Of GLP-1 Agonists 

In the ever-evolving landscape of medical science, certain discoveries stand out not just for their initial impact, but for their ability to continually reveal new and unexpected benefits. Glucagon-like peptide-1 receptor agonists (GLP-1 agonists) stand as prime examples of such pharmaceutical revelations. Initially developed for diabetes management and then repurposed for obesity treatment, these versatile compounds are now capturing attention for their potential cognitive benefits, further expanding their already impressive repertoire of clinical applications.

As the medical community increasingly focuses on brain health as a cornerstone of longevity, GLP-1 agonists have emerged as surprising contenders from an unexpected corner of pharmacology. This class of drugs, exemplified by semaglutide (marketed as Ozempic and Wegovy), challenges the conventional understanding of the intricate connections between metabolic health and cognitive longevity.

This latest chapter in the GLP-1 agonist saga is particularly significant given the growing concern over age-related cognitive decline and neurodegenerative diseases in an aging population. While lifestyle interventions such as diet and exercise remain foundational for brain health, the potential cognitive benefits of GLP-1 agonists represent an exciting new frontier in pharmacological approaches to healthy aging.

Continue reading

The Connection Between Aging, Cognitive Performance, and Oxidative Stress

Cognitive performance is a critical capability that allows individuals to function accordingly in their everyday lives; it provides humans with the capacity for sustenance and self-preservation and the free will to engage in activities of their choice. However, many researchers have posed a question regarding the sustainability of the human body’s cognitive performance, particularly because cognition may not be an all-enduring ability and is subject to different levels of degradation.

Several studies have proposed this concept, and research shows that several factors could affect a person’s cognitive ability, along with the discovery that multiple types of cognition correlate to specific functionality in the human body.

After several assessments of this proposed thesis, oxidative stress was considered one of the most significant factors correlated to a decrease in cognitive performance. This type of degradation is associated with the inherent decline of the body – aging.

Continue reading